Silence Therapeutics (SLN)

Sector:

Pharma and Biotech

Index:

FTSE AIM 50

530.00p
   
  • Change Today:
    -22.00p
  • 52 Week High: 649.00p
  • 52 Week Low: 339.00p
  • Currency: UK Pounds
  • Shares Issued: 89.74m
  • Volume: 69,390
  • Market Cap: £475.60m
  • RiskGrade: 177

Silence Therapeutics to present positive data from 'SLN124'

By Josh White

Date: Monday 07 Jun 2021

LONDON (ShareCast) - (Sharecast News) - Silence Therapeutics announced on Monday that it would present data showing the potential for 'SLN124' to address a range of hematological diseases by targeting the liver-expressed gene TMPRSS6.
The AIM-traded firm said the presentation would be made during two poster sessions at the European Hematology Association (EHA) virtual congress to be held from 9 June.

It said the presentations would include a preclinical safety assessment of SLN124, which would show data that was consistent with recent positive topline clinical data from the 'GEMINI' phase 1 study of SLN124 in healthy volunteers announced in May.

"SLN124 is being evaluated in the ongoing GEMINI II phase 1 study in patients with thalassemia and myelodysplastic syndrome," the board said in its statement.

"A second poster will present encouraging preclinical evidence that using siRNA to target TMPRSS6 could be a viable therapeutic avenue for treatment of the rare blood disorder, polycythaemia vera (PV)."

At 0933 BST, shares in Silence Therapeutics were up 1.09% at 639.91p.

Email this article to a friend

or share it with one of these popular networks:


Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

SLN Market Data

Currency UK Pounds
Share Price 530.00p
Change Today -22.00p
% Change -3.99 %
52 Week High 649.00p
52 Week Low 339.00p
Volume 69,390
Shares Issued 89.74m
Market Cap £475.60m
RiskGrade 177

SLN Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
43.45% below the market average43.45% below the market average43.45% below the market average43.45% below the market average43.45% below the market average
56% below the sector average56% below the sector average56% below the sector average56% below the sector average56% below the sector average
Price Trend
13.52% above the market average13.52% above the market average13.52% above the market average13.52% above the market average13.52% above the market average
25.81% above the sector average25.81% above the sector average25.81% above the sector average25.81% above the sector average25.81% above the sector average
Income Not Available
Growth
25.58% above the market average25.58% above the market average25.58% above the market average25.58% above the market average25.58% above the market average
22.22% above the sector average22.22% above the sector average22.22% above the sector average22.22% above the sector average22.22% above the sector average

What The Brokers Say

Strong Buy 4
Buy 0
Neutral 1
Sell 0
Strong Sell 0
Total 5
strong_buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

SLN Dividends

No dividends found

Trades for 21-Sep-2021

Time Volume / Share Price
17:08 5,001 @ 530.00p
16:35 3,017 @ 530.00p
16:27 3 @ 520.00p
16:27 197 @ 530.00p
16:27 150 @ 530.00p

Top of Page